{"id":"https://openalex.org/W4404014883","doi":"https://doi.org/10.1136/jitc-2024-009902","title":"Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase","display_name":"Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase","publication_year":2024,"publication_date":"2024-11-01","ids":{"openalex":"https://openalex.org/W4404014883","doi":"https://doi.org/10.1136/jitc-2024-009902","pmid":"https://pubmed.ncbi.nlm.nih.gov/39489542","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11535709"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2024-009902","doi":"https://doi.org/10.1136/jitc-2024-009902","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-009902","pdf_url":"https://jitc.bmj.com/content/jitc/12/11/e009902.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/12/11/e009902.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006817285","display_name":"Roberta Noseda","orcid":"https://orcid.org/0000-0002-4946-7926","observed_orcids":["https://orcid.org/0000-0002-4946-7926"]},"institutions":[{"id":"https://openalex.org/I4210095212","display_name":"Ente Ospedaliero Cantonale","ror":"https://ror.org/00sh19a92","country_code":"CH","type":"other","lineage":["https://openalex.org/I4210095212"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Roberta Noseda","raw_affiliation_strings":["Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-4946-7926","affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland","institution_ids":["https://openalex.org/I4210095212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035702540","display_name":"Francesca Bedussi","orcid":"https://orcid.org/0000-0002-8584-7408","observed_orcids":["https://orcid.org/0000-0002-8584-7408"]},"institutions":[{"id":"https://openalex.org/I4210095212","display_name":"Ente Ospedaliero Cantonale","ror":"https://ror.org/00sh19a92","country_code":"CH","type":"other","lineage":["https://openalex.org/I4210095212"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Francesca Bedussi","raw_affiliation_strings":["Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland","institution_ids":["https://openalex.org/I4210095212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084631806","display_name":"Valentina Giunchi","orcid":"https://orcid.org/0000-0001-5841-8520","observed_orcids":["https://orcid.org/0000-0001-5841-8520"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Valentina Giunchi","raw_affiliation_strings":["Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060485627","display_name":"Michele Fusaroli","orcid":"https://orcid.org/0000-0002-0254-2212","observed_orcids":["https://orcid.org/0000-0002-0254-2212"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Michele Fusaroli","raw_affiliation_strings":["Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069397170","display_name":"Emanuel Raschi","orcid":"https://orcid.org/0000-0003-0487-7996","observed_orcids":["https://orcid.org/0000-0003-0487-7996"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emanuel Raschi","raw_affiliation_strings":["Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy"],"raw_orcid":"https://orcid.org/0000-0003-0487-7996","affiliations":[{"raw_affiliation_string":"Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083393995","display_name":"Alessandro Ceschi","orcid":"https://orcid.org/0000-0002-4308-0405","observed_orcids":["https://orcid.org/0000-0002-4308-0405"]},"institutions":[{"id":"https://openalex.org/I4210095212","display_name":"Ente Ospedaliero Cantonale","ror":"https://ror.org/00sh19a92","country_code":"CH","type":"other","lineage":["https://openalex.org/I4210095212"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]},{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Alessandro Ceschi","raw_affiliation_strings":["Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland","Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland","Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland","Faculty of Biomedical Sciences, Universit\u00e0 della Svizzera italiana, Lugano, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland","institution_ids":["https://openalex.org/I4210095212"]},{"raw_affiliation_string":"Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland","institution_ids":["https://openalex.org/I4210100468"]},{"raw_affiliation_string":"Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland","institution_ids":["https://openalex.org/I4210095212"]},{"raw_affiliation_string":"Faculty of Biomedical Sciences, Universit\u00e0 della Svizzera italiana, Lugano, Switzerland","institution_ids":["https://openalex.org/I57201433"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5006817285"],"corresponding_institution_ids":["https://openalex.org/I4210095212"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":4.7921,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.96670477,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"12","issue":"11","first_page":"e009902","last_page":"e009902"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6455000042915344,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6455000042915344,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.3515999913215637,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7879999876022339},{"id":"https://openalex.org/keywords/individual-case-safety-reports","display_name":"individual case safety reports","score":0.8069999814033508},{"id":"https://openalex.org/keywords/vigibase","display_name":"VigiBase","score":0.8949999809265137},{"id":"https://openalex.org/keywords/thyroiditis","display_name":"thyroiditis","score":0.7129999995231628},{"id":"https://openalex.org/keywords/pneumonitis","display_name":"pneumonitis","score":0.9620000123977661},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hepatitis","display_name":"hepatitis","score":0.6029999852180481},{"id":"https://openalex.org/keywords/vitiligo","display_name":"vitiligo","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cutaneous-immune-related-adverse-events","display_name":"cutaneous immune-related adverse events","score":0.7940000295639038},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6930000185966492},{"id":"https://openalex.org/keywords/adverse-event-reporting","display_name":"adverse event reporting","score":0.4620000123977661},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6589999794960022},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.7820000052452087},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.7480000257492065},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9132260084152222},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7759057283401489},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5259050130844116},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4783884286880493},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4719471335411072},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.39687371253967285}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1136/jitc-2024-009902","doi":"https://doi.org/10.1136/jitc-2024-009902","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-009902","pdf_url":"https://jitc.bmj.com/content/jitc/12/11/e009902.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11535709","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11535709","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11535709/pdf/jitc-12-11.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmid:39489542","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39489542","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:www.zora.uzh.ch:265824","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/id/eprint/265824/1/jitc_12_11.pdf","pdf_url":"https://www.zora.uzh.ch/id/eprint/265824/1/jitc_12_11.pdf","source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Noseda, Roberta; Bedussi, Francesca; Giunchi, Valentina; Fusaroli, Michele; Raschi, Emanuel; Ceschi, Alessandro (2024). Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase. Journal for ImmunoTherapy of Cancer, 12(11):e009902.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:cris.unibo.it:11585/1004886","doi":null,"is_oa":true,"landing_page_url":"https://jitc.bmj.com/content/12/11/e009902.long","pdf_url":"https://jitc.bmj.com/content/12/11/e009902.full.pdf","source":{"id":"https://openalex.org/S4306402579","display_name":"Archivio istituzionale della ricerca (Alma Mater Studiorum Universit\u00e0 di Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210117483","host_organization_name":"Istituto di Ematologia di Bologna","host_organization_lineage":["https://openalex.org/I4210117483"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:2e05007eceb748b0a207f0589d95f95a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2e05007eceb748b0a207f0589d95f95a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)","raw_type":"article"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/223907","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/223907","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Noseda, R., Bedussi, F., Giunchi, V., Fusaroli, M., Raschi, E., & Ceschi, A. (2024). Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase. Journal for ImmunoTherapy of Cancer, 12, e009902. https://doi.org/10.1136/jitc-2024-009902","raw_type":"Journal Article"},{"id":"doi:10.5167/uzh-265824","doi":"https://doi.org/10.5167/uzh-265824","is_oa":true,"landing_page_url":"https://doi.org/10.5167/uzh-265824","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1136/jitc-2024-009902","doi":"https://doi.org/10.1136/jitc-2024-009902","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-009902","pdf_url":"https://jitc.bmj.com/content/jitc/12/11/e009902.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4404014883.pdf","grobid_xml":"https://content.openalex.org/works/W4404014883.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W2010121426","https://openalex.org/W2109653150","https://openalex.org/W2167186282","https://openalex.org/W2529373149","https://openalex.org/W2547133566","https://openalex.org/W2743419024","https://openalex.org/W2753432434","https://openalex.org/W2769632314","https://openalex.org/W2776592021","https://openalex.org/W2783137027","https://openalex.org/W2789315292","https://openalex.org/W2792804865","https://openalex.org/W2793167197","https://openalex.org/W2800428965","https://openalex.org/W2945590213","https://openalex.org/W2956028371","https://openalex.org/W3003854411","https://openalex.org/W3006932250","https://openalex.org/W3007177845","https://openalex.org/W3007610090","https://openalex.org/W3010839046","https://openalex.org/W3035943873","https://openalex.org/W3043591619","https://openalex.org/W3046013618","https://openalex.org/W3087697977","https://openalex.org/W3110536417","https://openalex.org/W3148902978","https://openalex.org/W3155554393","https://openalex.org/W4210370153","https://openalex.org/W4224270175","https://openalex.org/W4288033651","https://openalex.org/W4362474345","https://openalex.org/W4381470267","https://openalex.org/W4381510980","https://openalex.org/W4388990607","https://openalex.org/W4390129317","https://openalex.org/W4390752627","https://openalex.org/W4391843620","https://openalex.org/W4393084820","https://openalex.org/W4394690662","https://openalex.org/W4394793473","https://openalex.org/W4396696102","https://openalex.org/W4396696202"],"related_works":["https://openalex.org/W4404218256","https://openalex.org/W4393084820","https://openalex.org/W4410803690","https://openalex.org/W3155554393","https://openalex.org/W4408921523","https://openalex.org/W2901191795","https://openalex.org/W3023708550","https://openalex.org/W3082287626","https://openalex.org/W4417006250","https://openalex.org/W3167371728"],"abstract_inverted_index":{"BACKGROUND:":[0],"To":[1],"date,":[2],"evidence":[3],"on":[4,303],"late-onset":[5,39,64,78,108,175,228,283,314,344],"immune-related":[6],"adverse":[7],"events":[8],"(irAEs)":[9],"with":[10,35,41,61,74,115,144,209,230,285,295,316],"immune":[11],"checkpoint":[12],"inhibitors":[13],"(ICIs)":[14],"is":[15],"limited":[16],"to":[17,27,85,93,198,239,250,261,270,287,321,338],"a":[18,132,171],"small":[19],"number":[20],"of":[21,38,49,102,107,119,123,141,173,213,227,242,253,282,292,307,311,329],"clinical":[22],"cases.":[23],"This":[24,273],"study":[25,57,138,276],"aimed":[26],"identify":[28],"drug-":[29],"and":[30,99,104,131,193,263,289,309],"patient-related":[31,100],"characteristics":[32,101,291,326],"potentially":[33],"associated":[34,294],"the":[36,45,95,105,116,120,124,179,218,278,340],"reporting":[37,63,77,106,125,226,241,252,325],"irAEs":[40,65,146,229,244,255,284,315],"ICIs":[42,62,75,286,317],"in":[43,81],"VigiBase,":[44],"WHO":[46],"global":[47,274],"database":[48],"individual":[50],"case":[51,280],"safety":[52],"reports":[53],"(ICSRs).":[54],"METHODS:":[55],"Observational":[56],"comparing":[58],"deduplicated":[59],"ICSRs":[60,73,103,143,169,293],"(occurred":[66],">90":[67],"days":[68,205],"after":[69],"ICI":[70,201,231],"discontinuation)":[71],"versus":[72],"not":[76],"irAEs,":[79,176],"collected":[80],"VigiBase":[82],"from":[83,150],"2011":[84],"December":[86],"31,":[87],"2022.":[88],"Logistic":[89,221],"regression":[90,222],"was":[91,111,159,203],"used":[92],"model":[94],"relationship":[96],"between":[97],"drug-related":[98],"irAEs.":[109],"Significance":[110],"determined":[112],"for":[113],"variables":[114],"lower":[117],"bound":[118],"95%":[121,236,247,258,267],"CI":[122,237,248,259,268],"OR":[126],"(ROR)":[127],"higher":[128],"than":[129],"1":[130],"p":[133],"value":[134],"<0.05.":[135],"RESULTS:":[136],"The":[137],"population":[139],"consisted":[140],"6006":[142],"ICI-related":[145],"(4574,":[147],"76.2%,":[148],"originated":[149],"Europe;":[151],"3900,":[152],"64.9%,":[153],"involved":[154],"males;":[155],"median":[156],"patient":[157],"age":[158],"67":[160],"years,":[161],"IQR":[162],"59-74":[163],"years).":[164],"Of":[165],"these,":[166],"344":[167],"(5.7%)":[168],"reported":[170],"total":[172],"388":[174],"among":[177],"which":[178],"most":[180],"frequent":[181],"were":[182],"thyroiditis":[183],"(n=45),":[184],"pneumonitis":[185],"(n=37),":[186],"interstitial":[187],"lung":[188],"disease":[189],"(n=25),":[190],"hepatitis":[191],"(n=23)":[192],"vitiligo":[194],"(n=19).":[195],"Median":[196],"time":[197],"onset":[199],"since":[200],"discontinuation":[202,219],"167":[204],"(IQR":[206],"115-294":[207],"days),":[208],"negligible":[210],"proportion":[211],"(3.2%)":[212],"co-reported":[214],"antineoplastic":[215],"agents":[216],"during":[217],"period.":[220],"models":[223],"showed":[224],"disproportionate":[225,296],"combination":[232],"therapy":[233],"(ROR":[234,245,256,265],"2.33,":[235],"1.19":[238],"4.57),":[240],"multiple":[243],"3.96,":[246],"2.85":[249],"5.52),":[251],"cutaneous":[254],"1.83,":[257],"1.24":[260],"2.71),":[262],"melanoma":[264],"1.47,":[266],"1.04":[269],"2.06).":[271],"CONCLUSIONS:":[272],"pharmacovigilance":[275],"provides":[277],"largest":[279],"series":[281],"date":[288],"identifies":[290],"reporting.":[297],"Dedicated":[298],"prospective":[299],"observational":[300],"studies":[301],"focused":[302],"long-term":[304],"sequelae,":[305],"quality":[306],"life":[308],"survival":[310],"patients":[312],"developing":[313],"should":[318,335],"be":[319,336],"planned":[320],"confirm":[322],"whether":[323],"these":[324],"are":[327],"predictors":[328],"actual":[330],"occurrence.":[331],"Furthermore,":[332],"translational":[333],"research":[334],"encouraged":[337],"clarify":[339],"molecular":[341],"mechanisms":[342],"underlying":[343],"irAE":[345],"development.":[346]},"counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":12}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-11-04T00:00:00"}